Azik Hoffman
YOU?
Author Swipe
View article: Bladder Metastasis From Lung Adenocarcinoma: A Rare Case
Bladder Metastasis From Lung Adenocarcinoma: A Rare Case Open
Bladder metastasis from primary lung adenocarcinoma is an infrequent clinical entity. Due to its rarity and nonspecific presentation, it is often misdiagnosed as primary urothelial carcinoma. We report the case of a 65-year-old male with a…
View article: Preliminary Results of First-in-Human Intravesical Cryotherapy of Nonmuscle-invasive Bladder Cancer
Preliminary Results of First-in-Human Intravesical Cryotherapy of Nonmuscle-invasive Bladder Cancer Open
Introduction: Cryotherapy with CO2 is commonly used to treat superficial papillary lesions of the skin for many years. Following preliminary results in an animal model, we present our first-in-human phase 1 clinical safety trial and prelim…
View article: Evaluating the Survival Benefits of Perioperative Chemotherapy in Frail and Morbid Muscle-Invasive Bladder Cancer Patients
Evaluating the Survival Benefits of Perioperative Chemotherapy in Frail and Morbid Muscle-Invasive Bladder Cancer Patients Open
Introduction: Current guidelines endorse the use of perioperative chemotherapy (POC) in muscle-invasive bladder cancer (MIBC) to enhance the long-term overall survival (OS) compared to radical cystectomy (RC) alone. This study aims to asse…
View article: Prevention of Bladder Cancer Recurrence With the Botanical Formula LCS103: A Case Series Study
Prevention of Bladder Cancer Recurrence With the Botanical Formula LCS103: A Case Series Study Open
Despite effective chemotherapy and other available oncology treatments, recurrence rates for non-muscle invasive bladder cancer (NMIBC) remain high, with as many as 60% of patients requiring repeat intravesical treatments with BCG or other…
View article: The Impact of PSMA PET/CT on Modern Prostate Cancer Management and Decision Making—The Urological Perspective
The Impact of PSMA PET/CT on Modern Prostate Cancer Management and Decision Making—The Urological Perspective Open
Prostate-specific membrane antigen (PSMA) PET use in prostate cancer treatment has recently become a routinely used imaging modality by urologists. New, established data regarding its performance in different stages of prostate cancer, as …
View article: Data from Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 Trial
Data from Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 Trial Open
Purpose: Phenotypic biomarkers are a high priority for patients receiving androgen deprivation therapy (ADT) for prostate cancer given the increasing number of treatment options. This study evaluates serum sex steroids as prognostic biomar…
View article: Supplementary Figures 1-3, Supplementary Tables 1-5 from Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 Trial
Supplementary Figures 1-3, Supplementary Tables 1-5 from Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 Trial Open
Supplementary Figure 1. Consort diagram of patients included in study; Supplementary Figure 2. Schematic of sex steroids measured using mass spectrometry; Supplementary Figure 3. Prostate cancer survival and overall survival; Supplementary…
View article: Data from Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 Trial
Data from Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 Trial Open
Purpose: Phenotypic biomarkers are a high priority for patients receiving androgen deprivation therapy (ADT) for prostate cancer given the increasing number of treatment options. This study evaluates serum sex steroids as prognostic biomar…
View article: Supplementary Figures 1-3, Supplementary Tables 1-5 from Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 Trial
Supplementary Figures 1-3, Supplementary Tables 1-5 from Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 Trial Open
Supplementary Figure 1. Consort diagram of patients included in study; Supplementary Figure 2. Schematic of sex steroids measured using mass spectrometry; Supplementary Figure 3. Prostate cancer survival and overall survival; Supplementary…
View article: Analysis of Clinical Characteristics, Treatment Patterns, and Outcome of Patients with Bilateral Testicular Germ Cell Tumors
Analysis of Clinical Characteristics, Treatment Patterns, and Outcome of Patients with Bilateral Testicular Germ Cell Tumors Open
Introduction : Bilateral testicular germ cell tumor (BGCT) is a rare disease that is considered to be more aggressive than unilateral germ cell tumors (GCT). Among BGCT, a synchronous disease is more aggressive than the metachronous presen…
View article: Association between COVID-19 Burden, Population Vaccination Status, and Urologic Oncology Surgery Volume: A National Multicenter Cross-Sectional Study
Association between COVID-19 Burden, Population Vaccination Status, and Urologic Oncology Surgery Volume: A National Multicenter Cross-Sectional Study Open
Initial deleterious effects of the COVID-19 pandemic on urologic oncology surgeries are well described, but the possible influence of vaccination efforts and those of pandemic conditions on surgical volumes is unclear. Our aim was to exami…
View article: Fascial dehiscence after radical cystectomy: Is abdominal exploration mandatory?
Fascial dehiscence after radical cystectomy: Is abdominal exploration mandatory? Open
Background Fascial dehiscence after radical cystectomy may have serious clinical implications. To optimize its management, we sought to describe accompanying intraabdominal findings of post-cystectomy dehiscence repair and determine whethe…
View article: Association between Nuclear Morphometry Parameters and Gleason Grade in Patients with Prostatic Cancer
Association between Nuclear Morphometry Parameters and Gleason Grade in Patients with Prostatic Cancer Open
Objective: Gleason scoring system remains the pathological method of choice for prostate cancer (Pca) grading. However, this method of tumor tissue architectural structure grading is still affected by subjective assessment and might succum…
View article: Reply to Veerman et al. Comment on “Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410”
Reply to Veerman et al. Comment on “Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410” Open
We thank the commenters for their important insights [...]
View article: Association between early change in neutrophil‐to‐lymphocyte ratio after radical cystectomy and treatment outcomes
Association between early change in neutrophil‐to‐lymphocyte ratio after radical cystectomy and treatment outcomes Open
Objectives To evaluate the associations of peri‐operative neutrophil‐to‐lymphocyte ratio (NLR) and change in NLR with survival after radical cystectomy. Patients and Methods We retrospectively reviewed a multicentre cohort of patients with…
View article: Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates
Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates Open
Purpose: to evaluate a unique subpopulation of radical prostatectomy (RP) candidates with “negative” prostate 68Ga-labeled prostate-specific membrane antigen (PSMA) positron emission tomography (PET) computed tomography (CT) imaging scans …
View article: Can Endoscopic Appearance, Selective Cytology, and Pathological Sampling During Ureteroscopy Accurately Predict Tumor Grade of Upper-Tract Urothelial Carcinoma?
Can Endoscopic Appearance, Selective Cytology, and Pathological Sampling During Ureteroscopy Accurately Predict Tumor Grade of Upper-Tract Urothelial Carcinoma? Open
Objective: This study examined the reliability of the various parameters obtained in diagnostic ureteroscopy for upper-tract urothelial carcinoma (UTUC) in predicting the degree of differentiation in the final pathological report after rad…
View article: MP11-14 VERY LOW PROSTATE PET CT PSMA EXPRESSION MAY BE MISLEADING IN STAGING PROSTATECTOMY CANDIDATES
MP11-14 VERY LOW PROSTATE PET CT PSMA EXPRESSION MAY BE MISLEADING IN STAGING PROSTATECTOMY CANDIDATES Open
You have accessJournal of UrologyProstate Cancer: Staging (MP11)1 Sep 2021MP11-14 VERY LOW PROSTATE PET CT PSMA EXPRESSION MAY BE MISLEADING IN STAGING PROSTATECTOMY CANDIDATES Rennen Haramaty, Alon Lazarovich, Asaf Shvero, Miki Haifler, J…
View article: The use of biological glue (Starsil® Hemostat) in robotic partial nephrectomy: a safety and efficacy study
The use of biological glue (Starsil® Hemostat) in robotic partial nephrectomy: a safety and efficacy study Open
Introduction: Robotic partial nephrectomy (RPN) is a relatively safe nephron sparing surgery (NSS) approach for the treatment of small renal masses (cT1). However, a major perioperative complication is extensive bleeding and blood loss nec…
View article: PD17-05 HOW ACCURATE ARE GA68-PSMA PET/CT AND MULTIPARAMETRIC MRI IN EXCLUDING PELVIC LYMPH NODE METASTASES PRIOR TO RADICAL PROSTATECTOMY?
PD17-05 HOW ACCURATE ARE GA68-PSMA PET/CT AND MULTIPARAMETRIC MRI IN EXCLUDING PELVIC LYMPH NODE METASTASES PRIOR TO RADICAL PROSTATECTOMY? Open
You have accessJournal of UrologyProstate Cancer: Staging II (PD17)1 Apr 2019PD17-05 HOW ACCURATE ARE GA68-PSMA PET/CT AND MULTIPARAMETRIC MRI IN EXCLUDING PELVIC LYMPH NODE METASTASES PRIOR TO RADICAL PROSTATECTOMY? Michael Frumer*, Jack …
View article: Risk factors predicting fever following trans-urethral prostatectomy
Risk factors predicting fever following trans-urethral prostatectomy Open
Purpose: Fever occurring post transurethral resection of prostate (TURP) due to urinary tract infection (UTI) is a well-known complication. A better knowledge of pre-operative risk factors will aid the prevention and treatment of this comp…
View article: Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 Trial
Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 Trial Open
Purpose: Phenotypic biomarkers are a high priority for patients receiving androgen deprivation therapy (ADT) for prostate cancer given the increasing number of treatment options. This study evaluates serum sex steroids as prognostic biomar…
View article: Update on Screening for Urological Malignancies
Update on Screening for Urological Malignancies Open
Urological malignancies are a major source of morbidity and mortality in men over 40. Screening for those malignancies has a potential benefit of reducing both. However, even after more than two decades of screening for prostate cancer, th…
View article: Effect of Combination therapy of Desmopressin and Docetaxel on prostate cancer cell DU145 proliferation, migration and growth
Effect of Combination therapy of Desmopressin and Docetaxel on prostate cancer cell DU145 proliferation, migration and growth Open
Background: This study was designed to assess the efficacy of the combination of Desmopressin and Docetaxel for prostate cancer. Desmopressin has been demonstrated to inhibit tumor progression and metastasis in in vitro and in vivo models …
View article: Perioperative outcomes following radical prostatectomy for patients with disseminated cancer: An analysis of the National Surgical Quality Improvement Program database
Perioperative outcomes following radical prostatectomy for patients with disseminated cancer: An analysis of the National Surgical Quality Improvement Program database Open
Introduction: We sought to determine whether patients undergoing radical prostatectomy (RP) in the context of disseminated cancer have higher 30-day complications.Methods: We conducted a retrospective cohort study of the National Surgical …